Analysts' ratings for Beam Therapeutics (NASDAQ:BEAM) over the last quarter vary from bullish to bearish, as provided by 10 analysts. In the table below, you'll find a summary of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results